[FULC] YoY Quarter Result on 31-Dec-2019 [#Q3]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
05-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q3]
Profit Trend
QoQ- 2.53%
YoY- -82.00%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 871 685 5,058 4,225 0 0 -
PBT -24,756 -26,135 -23,484 -17,720 -16,123 -8,859 22.80%
Tax 3,161 -2,505 -621 -733 -879 -385 -
NP -24,756 -23,630 -23,484 -17,720 -16,123 -8,859 22.80%
Tax Rate - - - - - - -
Total Cost 25,627 24,315 28,542 21,945 16,123 8,859 23.65%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -2,842.25 -3,449.64 -464.29 -419.41 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.40 -0.45 -0.58 -0.64 -0.71 -0.52 -5.10%
EPS Diluted -0.40 -0.45 -0.58 -0.64 -0.71 -0.52 -5.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.